APOE epsilon-4 is the strongest common genetic risk for late-onset AD (about 3x heterozygous, 12x homozygous); affects A-beta clearance and lipid metabolism.
APOE epsilon-4 is the strongest common genetic risk for late-onset AD (about 3x heterozygous, 12x homozygous); affects A-beta clearance and lipid metabolism.